Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cecile L. Karsenty
Observed names:
Cecile Karsenty,
Cecile L Karsenty,
Cécile Karsenty
Institutions:
Baylor College of Medicine,
Texas Children's Hospital
Observed institutions:
University of Maryland, Baltimore,
Baylor College of Medicine,
Texas Children's Hospital,
University of Maryland School of Medicine
ORCID:
0000-0001-8901-0261
Observed ORCID:
0000-0001-8901-0261
OpenAlex ID:
A5041624249
Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
2022
·
Eran Tallis
, Cecile L. Karsenty
, et al.
·
JIMD Reports
·
21
Regional anesthesia for sickle cell disease vaso‐occlusive crisis: A single‐center case series
2022
·
Cecile Karsenty
, Venée N. Tubman
, et al.
·
Pediatric Blood & Cancer
·
19
Assessment of medical resident's attention to the health literacy level of newly admitted patients
2013
·
Cecile Karsenty
, Michael Landau
, et al.
·
Journal of Community Hospital Internal Medicine Perspectives
·
16
Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium
2022
·
Justine M. Kahn
, Kristen Stevenson
, et al.
·
Journal of Pediatric Hematology/Oncology Nursing
·
8
Molecular Diagnosis Is Vital to the Accurate Classification and Management of Thrombotic Thrombocytopenic Purpura in Children
2022
·
Cecile L. Karsenty
, Susan E. Kirk
, et al.
·
Frontiers in Immunology
·
7
PDF
Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department
2024
·
Josaura Fernandez Sanchez
, Luisanna M. Sánchez
, et al.
·
Pediatric Blood & Cancer
·
4
PDF
Rules, risks, and reality: rethinking gene therapy eligibility
2026
·
Cecile L. Karsenty
, Alexander I. Ngwube
·
Blood Advances
·
2
PDF
SaCas9 and AsCas12a Ultra enable highly efficient and specific gene editing in hematopoietic stem and progenitor cells
2026
·
ByoungYong Yoo
, Daniel Betancourth
, et al.
·
Cell Biomaterials
·
1
Complex HBB gene editing outcomes revealed by a fluorescent reporter cell model
2026
·
Cecile L. Karsenty
, Daniel Betancourth
, et al.
·
Molecular Therapy — Nucleic Acids
·
1
Gene-Editing-Based Approaches for Curing Sickle Cell Disease
2026
·
So Hyun Park
, Cecile Karsenty
, et al.
·
Springer eBooks
·
1
The transplant debate: defining innovation for sickle cell
2025
·
Cécile Karsenty
, Titilope Fasipe
, et al.
·
Blood Advances
·
1
Immunoglobulins As a Predictor of Chronicity in Pediatric Immune Thrombocytopenia
2023
·
Kirsty Hillier
, Derek MacMath
, et al.
·
Blood
·
1
PDF
Fluorescent Tagging of Endogenous Beta-Globin Gene in S-HUDEP2 Cell Model for Live Cell Monitoring of Beta-Globin Expression and Regulation
2022
·
Cecile Karsenty
, So Hyun Julie Park
, et al.
·
Blood
·
1
Characterization of Hemoglobin Variants Due to in-Frame Deletions in the β-Globin Gene from CRISPR/Cas9 Gene Correction for Sickle Cell Disease
2022
·
Alex Alex Pendergast
, So Hyun Park
, et al.
·
Blood
·
1
From approval to practice: are clinicians and health systems ready for gene therapy in sickle cell disease?
2026
·
Cecile L Karsenty
, Alexander I Ngwube
·
The Lancet Haematology
Referral variability and provider preparedness for pediatric sickle cell gene therapy: a national survey
2026
·
Cecile L. Karsenty
, Anil George
, et al.
·
Blood Immunology & Cellular Therapy
PDF
Provider practices and preparedness for gene therapy in pediatric sickle cell disease: A national survey of pediatric hematologists
2025
·
Cecile Karsenty
, Titilope Fasipe
, et al.
·
Blood
PDF
eP034: Novel use of global untargeted metabolomics in a patient with glycogen storage disease Ib receiving off label empagliflozin treatment
2022
·
Eran Tallis
, Cecile Karsenty
, et al.
·
Genetics in Medicine
Show more works
View as search
Works count:
18
Citation count:
84
H-index:
5
I10-index:
3
Year
Topic
Type